Skip to content

Comparison of regional cerebral oxygen saturation in total laparoscopic hysterectomy or myomectomy patients under general anesthesia with propofol, remimazolam, and sevoflurane.

Comparison of regional cerebral oxygen saturation in total laparoscopic hysterectomy or myomectomy patients under general anesthesia with propofol, remimazolam, and sevoflurane.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0007612
Enrollment
80
Registered
2022-08-05
Start date
2021-10-18
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Byfavo 50mg : remimazolam basylate 50mg remimazolam 6mg/kg/hr continuous injection at induction and 1-2mg/ kr/hr continuous injection after loss of consciousness Fresofol MCT injection 2

Sponsors

Daegu Fatima Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: patients aged 20 to 65 who underwent laparoscopic gynecological surgery under general anesthesia, patients with ASA score (American Society of anesthesiology physical state score) I and II..

Exclusion criteria

Exclusion criteria: Patients with a history of cerebrovascular disease, patients with uncontrolled hypertension, patients with a body mass index (BMI) of 25 or more, patients with drug allergies, patients with drug or alcohol addiction, patients with uncontrolled anemia

Design outcomes

Primary

MeasureTime frame
rSO2 level through Cerebral oximeter

Secondary

MeasureTime frame
Blood pressure, heart rate, bispectral index scale;Ramsay sedation scale 1. Patient anxious or agitated or both 2. Patient co-operative, oriented and tranquil 3. Patient responds to commands only 4. A brisk response to light glabellar tap 5.A sluggish response to light glabellar tap 6. No response 6

Countries

Korea, Republic of

Contacts

Public ContactJihyun An

Daegu Fatima Hospital

anji43@naver.com+82-53-940-7434

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026